Brad Weisgerber, Head Trader, joined Casdin Capital in 2015. He brings over 15 years of equity and options experience, including 10 years focused on trading in the Healthcare sector.
Prior to joining Casdin, Brad held positions at Pura Vida Investments and Weiss Multi-Strategy Advisors. Brad began his career on the Fixed Income Derivatives desk at JP Morgan Chase.
Brad earned a B.S. in Finance from Villanova University.
This person is not in any teams
This person is not in any offices
Casdin Capital
1 followers
Casdin Capital, LLC (“Casdin”) is a New York-based fundamental research investment firm focused on the life sciences and healthcare industry. The firm manages a long short equity fund and makes investments in early stage to late stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets under management. Casdin started from a position of curiosity, honesty, and passion to gain a deep and thoughtful understanding of opportunities in the life science ecosystem. They commit to finding the highest quality management teams doing the work to create high growth companies. They use data to continually advance their knowledge and we are long term investors. They believe in collaboration and transparency and operate at the forefront of innovation.